Age-stratified trends in the progression of spinal radiographic damage in patients with ankylosing spondylitis: a longitudinal study

Objective: The objective of this study was to investigate spinal radiographic progression in specific age ranges of ankylosing spondylitis (AS) patients. Methods: Longitudinal data for 1125 AS patients at a single hospital from 2000 to 2018 were retrospectively reviewed. Radiographic intervals were obtained from patients with consecutive spinal radiographs. The radiographic progression rate was defined as the modified Stoke Ankylosing Spondylitis Spinal Score (mSASSS) change per year within each interval. Using generalized estimating equations (GEEs), estimated marginal means were calculated for the mSASSS progression rate across age groups after adjusting for potential confounders. Results: We obtained 4016 radiographic intervals and stratified them into five groups based on patient age at the interval start: <20 (n = 122); 20–29 (n = 1124); 30–39 (n = 1690); 40–49 (n = 794); and ⩾50 years (n = 286). The mean (SD) mSASSS progression rate for all the intervals was 0.8 (1.9). The GEE-estimated mean mSASSS progression rate increased with age, peaking in the 30–39 age group with a value of 1.15 [95% confidence interval (CI) 1.03, 1.27], and decreased slightly thereafter. In the presence of risk factors, rapid progression occurred at earlier ages: the GEE-estimated mean mSASSS progression rate in those with elevated C-reactive protein levels and preexisting syndesmophytes was 2.82 (95% CI 1.93, 3.71) in the 20–29 age group. Conclusion: Spinal structural damage in AS seems to progress most rapidly when patients are age 30–39 years. An awareness of the trends in radiographic progression with advancing age could improve understanding of the natural course of AS.

[1]  R. Landewé,et al.  Biological DMARDs and disease modification in axial spondyloarthritis: a review through the lens of causal inference , 2021, RMD Open.

[2]  R. Inman.  Axial Spondyloarthritis: Current Advances, Future Challenges , 2021, Journal of rheumatic diseases.

[3]  J. Reveille,et al.  Ankylosing spondylitis risk factors: a systematic literature review , 2021, Clinical Rheumatology.

[4]  S. Park,et al.  Conventional disease-modifying antirheumatic drugs therapy may not slow spinal radiographic progression in ankylosing spondylitis: results from an 18-year longitudinal dataset , 2020, Therapeutic advances in musculoskeletal disease.

[5]  S. Park,et al.  Tumour necrosis factor inhibitors slow radiographic progression in patients with ankylosing spondylitis: 18-year real-world evidence , 2020, Annals of the Rheumatic Diseases.

[6]  D. Wiek.  AS Patient: How to Cope with the Lifelong and Changing Disease Challenges. , 2020, Rheumatic diseases clinics of North America.

[7]  M. Murad,et al.  Effect of Therapy on Radiographic Progression in Axial Spondyloarthritis: A Systematic Review and Meta‐Analysis , 2020, Arthritis & rheumatology.

[8]  N. Horwood,et al.  Loss and gain of bone in spondyloarthritis: what drives these opposing clinical features? , 2020, Therapeutic advances in musculoskeletal disease.

[9]  L. Gensler,et al.  Biologic therapy and spinal radiographic progression in patients with axial spondyloarthritis: A structured literature review , 2020, Therapeutic advances in musculoskeletal disease.

[10]  L. Gossec,et al.  The European Map of Axial Spondyloarthritis: Capturing the Patient Perspective—an Analysis of 2846 Patients Across 13 Countries , 2019, Current Rheumatology Reports.

[11]  D. Gladman,et al.  Predicting adherence to therapy in rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis: a large cross-sectional study , 2019, RMD Open.

[12]  S. Aydın,et al.  The role of obesity on inflammation and damage in spondyloarthritis: a systematic literature review on body mass index and imaging. , 2019, Clinical and experimental rheumatology.

[13]  M. Soucek,et al.  AXIAL SPONDYLOARTHRITIS , 2023 .

[14]  F. Berenbaum,et al.  Development and psychometric validation of a patient-reported outcome measure to assess fears in rheumatoid arthritis and axial spondyloarthritis: the Fear Assessment in Inflammatory Rheumatic diseases (FAIR) questionnaire , 2017, Annals of the rheumatic diseases.

[15]  R. Anguiano,et al.  Medication adherence and persistence over time with self-administered TNF-alpha inhibitors among young adult, middle-aged, and older patients with rheumatologic conditions. , 2017, Seminars in arthritis and rheumatism.

[16]  M. Guerra,et al.  The effect of smoking on clinical and structural damage in patients with axial spondyloarthritis: A systematic literature review. , 2017, Seminars in arthritis and rheumatism.

[17]  R. Landewé,et al.  MRI vertebral corner inflammation followed by fat deposition is the strongest contributor to the development of new bone at the same vertebral corner: a multilevel longitudinal analysis in patients with ankylosing spondylitis , 2015, Annals of the rheumatic diseases.

[18]  M. Dougados,et al.  Lifestyle factors may modify the effect of disease activity on radiographic progression in patients with ankylosing spondylitis: a longitudinal analysis , 2015, RMD Open.

[19]  Peter M. A. van Ooijen,et al.  Spinal Radiographic Progression in Patients with Ankylosing Spondylitis Treated with TNF-α Blocking Therapy: A Prospective Longitudinal Observational Cohort Study , 2015, PloS one.

[20]  M. Dougados,et al.  Evolution of radiographic damage in ankylosing spondylitis: a 12 year prospective follow-up of the OASIS study , 2013, Annals of the rheumatic diseases.

[21]  F. Berenbaum,et al.  Fears and Beliefs in Rheumatoid Arthritis and Spondyloarthritis: A Qualitative Study , 2014, PloS one.

[22]  Tae-Hwan Kim,et al.  The presence of peripheral arthritis delays spinal radiographic progression in ankylosing spondylitis: Observation Study of the Korean Spondyloarthropathy Registry. , 2014, Rheumatology.

[23]  A. Ramanan,et al.  Juvenile Versus Adult-onset Ankylosing Spondylitis — Clinical, Radiographic, and Social Outcomes. A Systematic Review , 2013, The Journal of Rheumatology.

[24]  W. Hamilton,et al.  Raised inflammatory markers , 2012, BMJ : British Medical Journal.

[25]  M. Dougados,et al.  Development of new syndesmophytes and bridges in ankylosing spondylitis and their predictors: a longitudinal study , 2011, Annals of the rheumatic diseases.

[26]  L. Quine,et al.  Living with Ankylosing Spondylitis , 2009, Journal of health psychology.

[27]  J. Braun,et al.  The Natural Course of Radiographic Progression in Ankylosing Spondylitis — Evidence for Major Individual Variations in a Large Proportion of Patients , 2009, The Journal of Rheumatology.

[28]  M. Dougados,et al.  Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis , 2008, Annals of the rheumatic diseases.

[29]  K. Gaffney,et al.  Predicting outcome in ankylosing spondylitis. , 2008, Rheumatology.

[30]  J. Reveille,et al.  Occupational physical activities and long-term functional and radiographic outcomes in patients with ankylosing spondylitis. , 2008, Arthritis and rheumatism.

[31]  J. Reveille,et al.  Impact of ankylosing spondylitis on work and family life: comparisons with the US population. , 2008, Arthritis and rheumatism.

[32]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Preventive medicine.

[33]  Matthias Egger,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies , 2007, PLoS medicine.

[34]  M. A. van 't Hof,et al.  Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system , 2004, Annals of the rheumatic diseases.

[35]  M. Dougados,et al.  Scoring of radiographic progression in randomised clinical trials in ankylosing spondylitis: a preference for paired reading order , 2004, Annals of the rheumatic diseases.

[36]  M. Khan,et al.  Ankylosing spondylitis: introductory comments on its diagnosis and treatment , 2002, Annals of the rheumatic diseases.

[37]  Sinead Brophy,et al.  The natural history of ankylosing spondylitis as defined by radiological progression. , 2002, The Journal of rheumatology.

[38]  E Leventhal,et al.  Medication Adherence in Rheumatoid Arthritis Patients: Older Is Wiser , 1999, Journal of the American Geriatrics Society.

[39]  A. Cats,et al.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. , 1984, Arthritis and rheumatism.